NCT04366154

Brief Summary

This original study will assess the impact of the coronavirus health crisis on the management of patients undergoing medical treatment for cancer, in particularly on the modification of the hospital organization. It will also provide a record of the progress of patients who will have been treated during the epidemic period and infected by the virus. We will also assess the psychological impact of the pandemic in patients but also in caregivers

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
809

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 16, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 28, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

3 months

First QC Date

April 16, 2020

Last Update Submit

December 11, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • To assess the impact of the COVID-19 pandemic on the modifications of treatments administered in hospital (day units) to patients with cancer or malignant hemopathy

    Proportion of patients with modification of the treatments administered

    up to 6 months

  • To assess the impact of the COVID-19 pandemic on the change in the rate of treatment administration in hospital (day units) to patients with cancer or malignant hemopathy

    Proportion of patients with change in the rate of treatment administration

    up to 6 months

  • To assess the impact of the COVID-19 pandemic on the number of cures administeredin hospital (day units) to patients with cancer or malignant hemopathy

    Proportion of patients with change in the number of cures administered

    up to 6 months

  • To assess the impact of the COVID-19 pandemic on change of modality of administration in hospital (day units) to patients with cancer or malignant hemopathy

    Proportion of patients with change of modality of administration (home administration to replace day hospital administration, teleconsultation uses)

    up to 6 months

Secondary Outcomes (9)

  • Evaluate the perceived stress on cancer patients treated in unit day of hospital

    up to 12 months

  • Evaluate the post-traumatic stress on cancer patients treated in unit day of hospital

    up to 12 months

  • Evaluate the sleep disorders on cancer patients treated in unit day of hospital

    up to 12 months

  • Evaluate the quality of life on cancer patients treated in unit day of hospital

    up to 12 months

  • Evaluate the cognitive complaints on cancer patients treated in unit day of hospital

    up to 12 months

  • +4 more secondary outcomes

Study Arms (2)

Patients

Other: Questionnaire

Caregivers

Other: Questionnaire

Interventions

delivery of questionnaires on perceived stress, post-traumatic stress, sleep disorders, quality of life, cognitive complaint

CaregiversPatients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

2 populations were recruted in this study : patients with cancer and caregivers

You may qualify if:

  • For Patients:
  • Adult patient, treated for a solid or hematological tumor
  • will be treated ou actually treated by oncological treatment carried out at the hospital in day unit of the participating centers: treatment initiated before or during the pandemic with COVID-19
  • For the Caregivers:
  • \- Medical oncologist, hematologist, intern, nurse and caregiver in day unit of hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre François Baclesse

Caen, France

Location

Centre Henri Becquerel

Rouen, France

Location

Related Publications (2)

  • Cherifi F, Gernier F, Jardin F, Lefevre-Arbogast S, Bastien E, Lequesne J, Rigal O, Quilan F, Clarisse B, Grellard JM, Binarelli G, Fernette M, Lange M, Richard D, Morel A, Griffon B, Pepin LF, Leconte A, Faveyrial A, Leheurteur M, Beauplet B, Joly F. Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic. J Geriatr Oncol. 2023 Nov;14(8):101634. doi: 10.1016/j.jgo.2023.101634. Epub 2023 Sep 25.

  • Bastien E, Lefevre-Arbogast S, Lequesne J, Gernier F, Cherifi F, Rigal O, Guittet L, Grellard JM, Binarelli G, Lange M, Fernette M, Tron L, Morel A, Richard D, Griffon B, Leconte A, Quilan F, Pepin LF, Jardin F, Leheurteur M, Faveyrial A, Clarisse B, Joly F. Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study. J Natl Compr Canc Netw. 2023 Feb 22;21(3):265-272.e7. doi: 10.6004/jnccn.2023.7085.

MeSH Terms

Conditions

COVID-19Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2020

First Posted

April 28, 2020

Study Start

April 15, 2020

Primary Completion

July 15, 2020

Study Completion

May 1, 2021

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations